SCLN Financial Facts

Sales and marketing: 13.91M
Interest and investment income: 31K
See Full Income Statement

Accounts payable: 6.36M
Accumulated other comprehensive income: 3.71M
See Full Balance Sheet

SciClone Pharmaceuticals, Inc. (SCLN) Earnings

  |   Expand Research on SCLN
Next EPS Date 1/2/15 *Est. EPS Growth Rate -5.6% *Last Qtr.
Average EPS % Beat Rate +30.0% Revenue Growth Rate -2.6% *Last Qtr.
Average % Move 1-Wk after EPS +7.2% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/10/14 Q314 $0.17$0.12 +$0.05$34.3M$34.9M Details
8/11/14 Q214 $0.20$0.10 +$0.10$32.5M$33.4M Details
5/12/14 Q114 $0.10$0.08 +$0.02$26.6M$32.2M Details
4/1/13 Q413 $0.04$0.12 -$0.08$33.1M$35.3M Details
3/12/14 Q413 $0.08$0.15 -$0.07$32.7M$38.3M Details
11/12/13 Q313 $0.18$0.15 +$0.03$35.2M$39.7M = Details
8/7/13 Q213 $0.09$0.11 -$0.02$29.81M$33.3M = Details
11/9/12 Q312 $0.20$0.21 -$0.01$40.7M$44.8M Details